Table 2 Aggregated results of Working Group 3 (A, B, and C)
From: Evaluation of dialysis centres: values and criteria of the stakeholders
Patients | Clinicians | Managers | Total | |||
|---|---|---|---|---|---|---|
(n = 9) | (n = 9) | (n = 8) | (n = 26) | |||
Criteria | Sub-criteria | Methodology | ||||
EBV | WS | 26.11 (10.83) | 26.66 (7.50) | 24.37 (10.16) | 25.77 (9.24) | |
AHP | 20.31 (15.06) | 24.62 (17.60) | 29.50 (22.25) | 24.63 (18.02) | ||
Type of vascular access | WS | 25.55 (8.46) | 26.67 (4.33) | 28.75 (5.18) | 26.92 (6.17) | |
AHP | 41.66 (11.38) | 40.42 (11.41) | 31.98 (14.37) | 38.25 (12.63) | ||
Dialysis dose | WS | 26.11 (8.21) | 20.56 (3.01) | 21.87 (5.94) | 22.88 (6.35) | |
AHP | 18.63 (10.45) | 21.17 (11.19) | 19.75 (11.95) | 19.85 (10.78) | ||
Haemoglobin concentration | WS | 16.11 (4.17) | 18.33 (2.50) | 15.62 (4.17) | 16.73 (3.73) | |
AHP | 13.36 (6.18) | 11.03 (7.57) | 10.61 (7.00) | 11.71 (6.78) | ||
Ratio of bacteraemia related to the catheter | WS | 16.11 (8.21) | 21.67 (7.50) | 25.00 (3.78) | 20.77 (7.57) | |
AHP | 19.93 (11.95) | 23.61 (10.91) | 19.29 (20.68) | 21.01 (14.40) | ||
Mineral and bone disease | WS | 16.11 (6.97) | 12.78 (7.12) | 8.75 (3.54) | 12.69 (6.67) | |
AHP | 6.42 (3.47) | 3.77 (0.99) | 18.36 (14.22) | 9.18 (10.05) | ||
Morbidity, annual | WS | 15.56 (7.68) | 18.89 (5.46) | 18.37 (8.43) | 17.57 (7.12) | |
AHP | 23.06 (7.98) | 13.15 (9.35) | 15.72 (9.88) | 17.38 (9.72) | ||
Mortality, annual | WS | 12.22 (7.55) | 18.89 (6.50) | 20.00 (9.26) | 16.92 (8.26) | |
AHP | 13.76 (13.75) | 20.51 (20.71) | 20.68 (20.02) | 18.23 (17.91) | ||
PROMs | WS | 28.33 (5.00) | 21.67 (4.33) | 26.25 (7.44) | 25.38 (6.15) | |
AHP | 36.26 (16.76) | 31.93 (12.45) | 23.33 (13.23) | 30.78 (14.75) | ||
PREMs | WS | 17.78 (6.18) | 13.89 (3.33) | 11.00 (2.56) | 14.34 (5.05) | |
AHP | 6.61 (3.35) | 9.77 (5.78) | 10.75 (11.94) | 8.98 (7.58) | ||